Circulating Protein Biomarkers in Breast Cancer: Clinical Significance and Integration with Molecular Signature
1. Abstract Breast cancer is biologically heterogeneous; the best way to manage the disease is to have biomarkers that represent the fixed molecular phenotype of the tumor in addition to a dynamic.









